Products Categories
CAS No.: | 64808-48-6 |
---|---|
Name: | BENZOIC ACID, 2-[(2-CARBOXYPHENYL)AMINO]-4-CHLORO-, DISODIUM SALT |
Article Data: | 1 |
Molecular Structure: | |
Formula: | C14H10 Cl N O4 . 2 Na |
Molecular Weight: | 335.654 |
Synonyms: | Benzoicacid, 2-[(2-carboxyphenyl)amino]-4-chloro-, disodium salt (9CI); CCA; Carfenil;Disodium N-(2-carboxyphenyl)-4-chloroanthranilic acid; Lobenzarit disodium;Lobenzarit disodium salt; Lobenzarit sodium |
Melting Point: | 388° (dec) |
Boiling Point: | 481°C at 760 mmHg |
Flash Point: | 244.7°C |
Solubility: | Soluble in water |
Safety: | Poison by intravenous, subcutaneous, and intraperitoneal routes. Moderately toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and Cl−. |
PSA: | 92.29000 |
LogP: | 0.88360 |
Conditions | Yield |
---|---|
In sodium hydroxide; water |
Carfenil
[4-chloro-2-(2-hydroxymethyl-phenylamino)-phenyl]-methanol
Conditions | Yield |
---|---|
With hydrogenchloride; borane-THF; water In tetrahydrofuran at 0 - 20℃; | 95% |
Carfenil
3-chloro-12,13-dimethoxy-10,15-dihydro-5H-5-aza-tribenzo[a,d,g]cyclononene
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: 95 percent / HCl; H2O; BH3*THF / tetrahydrofuran / 0 - 20 °C 2: 68 percent / H2SO4 / various solvent(s) / 0 °C View Scheme |
Carfenil
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: 95 percent / HCl; H2O; BH3*THF / tetrahydrofuran / 0 - 20 °C 2: 68 percent / H2SO4 / various solvent(s) / 0 °C 3: 47 percent / NaH / dimethylsulfoxide / Heating View Scheme |
Carfenil
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: 95 percent / HCl; H2O; BH3*THF / tetrahydrofuran / 0 - 20 °C 2: 68 percent / H2SO4 / various solvent(s) / 0 °C 3: 66 percent / NaH / dimethylsulfoxide / Heating View Scheme |
What can I do for you?
Get Best Price
IUPAC Name: disodium 2-(2-carboxylatoanilino)-4-chlorobenzoate
Synonyms of Lobenzarit disodium (CAS NO.64808-48-6): Lobenzarit disodium salt ; Lobenzarit sodium [USAN] ; 2-((2-Carboxyphenyl)amino)-4-chlorobenzoic acid disodium salt ; Benzoic acid, 2-((2-carboxyphenyl)amino)-4-chloro-, disodium salt ; CCRIS 8090 ; Disodium 4-chloro-2,2'-iminobenzoate ; Disodium 4-chloro-2,2'-iminodibenzoate ; Lobenzarit sodium ; UNII-7Z9SP74BXF ;
CAS NO: 64808-48-6
Molecular Formula of Lobenzarit disodium (CAS NO.64808-48-6): C14H8ClNNa2O4
Molecular Weight: 335.6502
H bond acceptors: 5
H bond donors: 3
Freely Rotating Bonds: 4
Polar Surface Area: 77.84 Å2
Flash Point: 244.7 °C
Enthalpy of Vaporization of Lobenzarit disodium (CAS NO.64808-48-6): 78.54 kJ/mol
Boiling Point: 481 °C at 760 mmHg
Vapour Pressure: 4.62E-10 mmHg at 25°C
Molecular Structure:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 320mg/kg (320mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: FLUID INTAKE SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 4579, 1987. |
mouse | LD50 | intravenous | 400mg/kg (400mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) SKIN AND APPENDAGES (SKIN): HAIR: OTHER BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 4579, 1987. |
mouse | LD50 | oral | 740mg/kg (740mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 4579, 1987. |
mouse | LD50 | subcutaneous | 500mg/kg (500mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 4579, 1987. |
rat | LD50 | intraperitoneal | 263mg/kg (263mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: FLUID INTAKE BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 4579, 1987. |
rat | LD50 | oral | 1150mg/kg (1150mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: FLUID INTAKE BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 4579, 1987. |
rat | LD50 | subcutaneous | 314mg/kg (314mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: FLUID INTAKE BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 4579, 1987. |
Poison by intravenous, subcutaneous, and intraperitoneal routes. Moderately toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and Cl−.